Combined versus sequential antracycline and taxane adjuvant regimens in triple negative breast cancer patients.

Oguz A., Keskin G. S. Y., Akcali Z., Colak D., Altundag O., Altundag M. K.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 3 - 07 June 2016, vol.34 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 34
  • Doi Number: 10.1200/jco.2016.34.15_suppl.e12578
  • City: Illinois
  • Country: United States Of America
  • Hacettepe University Affiliated: Yes